{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T18:59:45Z","timestamp":1772477985674,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2415-14-42","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T07:02:50Z","timestamp":1396335770000},"source":"Crossref","is-referenced-by-count":20,"title":["Assessment of the effect of iris colour and having children on 5-year risk of death after diagnosis of uveal melanoma: a follow-up study"],"prefix":"10.1186","volume":"14","author":[{"given":"Andrea","family":"Schmidt-Pokrzywniak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Kalbitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Kuss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Heinz","family":"J\u00f6ckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Bornfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Stang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,1]]},"reference":[{"key":"417_CR1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ijc.20690","volume":"114","author":"A Stang","year":"2005","unstructured":"Stang A, Parkin DM, Ferlay J, J\u00f6ckel KH: International uveal melanoma trends in a view of a decreasing proportion of morphological verification. Int J Cancer. 2005, 114: 114-123. 10.1002\/ijc.20690.","journal-title":"Int J Cancer"},{"key":"417_CR2","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.ophtha.2007.01.032","volume":"114","author":"G Virgili","year":"2007","unstructured":"Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Bigger A, Crocetti E, Lutz JM, Paci E: Incidence of uveal melanoma in Europe. Ophthalmology. 2007, 114: 2309-2315. 10.1016\/j.ophtha.2007.01.032.","journal-title":"Ophthalmology"},{"key":"417_CR3","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1167\/iovs.03-0081","volume":"44","author":"L Bergman","year":"2003","unstructured":"Bergman L, Seregard S, Nilsson B, Lundell G, Ringborg U, Ragnarsson-Olding B: Uveal melanoma survival in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci. 2003, 44: 3282-3287. 10.1167\/iovs.03-0081.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"417_CR4","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1001\/archopht.126.10.1413","volume":"126","author":"G Virgili","year":"2008","unstructured":"Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, Lutz JM, Paci E: Survival in patients with uveal melanoma in Europe. Arch Ophthalmol. 2008, 126: 1413-1418. 10.1001\/archopht.126.10.1413.","journal-title":"Arch Ophthalmol"},{"key":"417_CR5","first-page":"1881","volume":"118","author":"AD Singh","year":"2011","unstructured":"Singh AD, Turell ME, Topham AK: Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology. Review. 2011, 118: 1881-1885.","journal-title":"Review"},{"key":"417_CR6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/eye.2011.272","volume":"26","author":"BE Damato","year":"2012","unstructured":"Damato BE, Coupland SE: Differences in uveal melanomas between men and women from the British Isles. Eye (Lond). 2012, 26: 292-299. 10.1038\/eye.2011.272.","journal-title":"Eye (Lond)"},{"issue":"Suppl 6","key":"417_CR7","first-page":"936","volume":"138","author":"BS Hawkins","year":"2004","unstructured":"Hawkins BS, Collaborative Ocular Melanoma Study Group: The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. Am J Ophthalmol. 2004, 138 (Suppl 6): 936-951.","journal-title":"Am J Ophthalmol"},{"key":"417_CR8","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.5858\/2010-0477-OAR1","volume":"135","author":"IH Bronkhorst","year":"2011","unstructured":"Bronkhorst IH, Maat W, Jordanova ES, Jordanova ES, Kroes WGM, Schalij-Delfos NE, Luyten GPM, Jager MJ: Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma. Arch Pathol Lab Med. 2011, 135: 1042-1047. 10.5858\/2010-0477-OAR1.","journal-title":"Arch Pathol Lab Med"},{"key":"417_CR9","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/S0140-6736(96)90736-9","volume":"347","author":"N Bornfeld","year":"1996","unstructured":"Bornfeld N, Prescher G, Becher R, Hirche H, J\u00f6ckel KH, Horsthemke B: Prognostic implications of monosomy 3 in uveal melanoma. Lancet. 1996, 347: 1222-1225. 10.1016\/S0140-6736(96)90736-9.","journal-title":"Lancet"},{"key":"417_CR10","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.ophtha.2007.06.012","volume":"114","author":"B Damato","year":"2007","unstructured":"Damato B, Duke C, Coupland SE, Hiscott P, Smith PA, Campbell I, Douglas A, Howard P: Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology. 2007, 114: 1925-1931. 10.1016\/j.ophtha.2007.06.012.","journal-title":"Ophthalmology"},{"key":"417_CR11","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.ophtha.2005.04.020","volume":"112","author":"CP Shah","year":"2005","unstructured":"Shah CP, Weis E, Lajous M, Shields JA, Shields CL: Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis. Ophthalmology. 2005, 112: 1599-1607. 10.1016\/j.ophtha.2005.04.020.","journal-title":"Ophthalmology"},{"key":"417_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1001\/archopht.124.1.54","volume":"124","author":"E Weis","year":"2006","unstructured":"Weis E, Shah CP, Lajous M, Shields JA, Shields CL: The association between host susceptibility factors and uveal melanoma: a meta-analysis. Arch Ophthalmol. 2006, 124: 54-60. 10.1001\/archopht.124.1.54.","journal-title":"Arch Ophthalmol"},{"key":"417_CR13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ophtha.2008.09.040","volume":"116","author":"A Schmidt-Pokrzywniak","year":"2009","unstructured":"Schmidt-Pokrzywniak A, J\u00f6ckel KH, Bornfeld N, Sauerwein W, Stang A: Positive interaction between light iris color and ultraviolet radiation in relation to the risk of uveal melanoma: a case\u2013control study. Ophthalmology. 2009, 116: 340-348. 10.1016\/j.ophtha.2008.09.040.","journal-title":"Ophthalmology"},{"issue":"Suppl 6","key":"417_CR14","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/archopht.117.6.811","volume":"117","author":"S Regan","year":"1999","unstructured":"Regan S, Judge HE, Gragoudas ES, Egan KM: Iris color as a prognostic factor in ocular melanoma. Arch Ophthalmol. 1999, 117 (Suppl 6): 811-814.","journal-title":"Arch Ophthalmol"},{"key":"417_CR15","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1001\/archopht.117.7.939","volume":"117","author":"KM Egan","year":"1999","unstructured":"Egan KM, Quinn JL, Gragoudas ES: Childbearing history associated with improved survival in choroidal melanoma. Arch Ophthalmol. 1999, 117: 939-942. 10.1001\/archopht.117.7.939.","journal-title":"Arch Ophthalmol"},{"key":"417_CR16","first-page":"280","volume":"11","author":"S Frenkel","year":"2009","unstructured":"Frenkel S, Hendler K, Pe\u2019er J: Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis. Isr Med Assoc J. 2009, 11: 280-285.","journal-title":"Isr Med Assoc J"},{"key":"417_CR17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/eye.2008.54","volume":"23","author":"SA Cook","year":"2009","unstructured":"Cook SA, Damato B, Marshall E, Salmon P: Psychological aspects of cytogenetic testing of uveal melanoma: preliminary findings and directions for future research. Eye (Lond). 2009, 23: 581-585. 10.1038\/eye.2008.54.","journal-title":"Eye (Lond)"},{"key":"417_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1369-7625.2010.00639.x","volume":"14","author":"SA Cook","year":"2011","unstructured":"Cook SA, Damato B, Marshall E, Salmon P: Reconciling the principle of patient autonomy with the practice of informed consent: decision-making about prognostication in uveal melanoma. Health Expect. 2011, 14: 383-396. 10.1111\/j.1369-7625.2010.00639.x.","journal-title":"Health Expect"},{"key":"417_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2415-4-11","volume":"4","author":"A Schmidt-Pokrzywniak","year":"2004","unstructured":"Schmidt-Pokrzywniak A, J\u00f6ckel KH, Bornfeld N, Stang A: Case\u2013control study on uveal melanoma (RIFA): rational and design. BMC Ophthalmol. 2004, 4: 11-10.1186\/1471-2415-4-11.","journal-title":"BMC Ophthalmol"},{"key":"417_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00001648-199901000-00008","volume":"10","author":"S Greenland","year":"1999","unstructured":"Greenland S, Pearl J, Robins JM: Causal diagrams for epidemiologic research. Epidemiology. 1999, 10: 37-48. 10.1097\/00001648-199901000-00008.","journal-title":"Epidemiology"},{"key":"417_CR21","first-page":"74","volume-title":"Proceedings of the Western Users of Sas Software Conference","author":"I Stijacic Cenzer","year":"2012","unstructured":"Stijacic Cenzer I, Miao Y, Kirby K, Boscardin WJ: Estimating Harrell\u2019s optimism on predictive indices using bootstrap samples. Proceedings of the Western Users of Sas Software Conference. 2012, 74-12."},{"key":"417_CR22","unstructured":"SAS Institute Inc., Cary, NC, USA: SAS for windows Version 9.2[computer program]."},{"key":"417_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1055\/s-2004-813850","volume":"67","author":"W Hoffmann","year":"2005","unstructured":"Hoffmann W, Latza U, Terschuren C: Guidelines and recommendations for ensuring Good Epidemiological Practice (GEP) - revised version after evaluation. Gesundheitswesen. 2005, 67: 217-222. 10.1055\/s-2004-813850.","journal-title":"Gesundheitswesen"},{"key":"417_CR24","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0360-3016(02)04200-1","volume":"55","author":"E Egger","year":"2003","unstructured":"Egger E, Zografos L, Schalenbourg A, Beati D, Bhringer T, Chamot L, Goitein G: Eye retention after proton beam radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys. 2003, 55: 867-880. 10.1016\/S0360-3016(02)04200-1.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"417_CR25","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0161-6420(90)32512-5","volume":"97","author":"JM Seddon","year":"1990","unstructured":"Seddon JM, Gragoudas ES, Egan KM, Glynn RJ, Howard S, Fante RG, Albert DM: Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology. 1990, 97: 769-777. 10.1016\/S0161-6420(90)32512-5.","journal-title":"Ophthalmology"},{"key":"417_CR26","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1167\/iovs.03-0538","volume":"44","author":"E Kujala","year":"2003","unstructured":"Kujala E, M\u00e4kitie T, Kivel\u00e4 T: Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003, 44: 4651-4659. 10.1167\/iovs.03-0538.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"417_CR27","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ophtha.2004.11.038","volume":"112","author":"L Bergman","year":"2005","unstructured":"Bergman L, Nilsson B, Lundell G, Lundell M, Seregard S: Ruthenium brachytherapy for uveal melanoma, 1979\u20132003: survival and functional outcomes in the Swedish population. Ophthalmology. 2005, 112: 834-840. 10.1016\/j.ophtha.2004.11.038.","journal-title":"Ophthalmology"},{"key":"417_CR28","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1016\/j.ejca.2004.06.028","volume":"40","author":"A Schmittel","year":"2004","unstructured":"Schmittel A, Bechrakis NE, Martus P, Mutlu D, Scheibenbogen C, Bornfeld N, Foerster MH, Thiel E, Keilholz U: Independent prognostic factors for distant metastases and survival in patients with primary uveal melanoma. Eur J Cancer. 2004, 40: 2389-2395. 10.1016\/j.ejca.2004.06.028.","journal-title":"Eur J Cancer"},{"issue":"Suppl 12","key":"417_CR29","first-page":"1684","volume":"124","author":"Collaborative Ocular Melanoma Study Group","year":"2006","unstructured":"Collaborative Ocular Melanoma Study Group: The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: Twelve-year mortality rates and prognostic factors. Arch Ophthalmol. 2006, 124 (Suppl 12): 1684-1693.","journal-title":"Arch Ophthalmol"},{"key":"417_CR30","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/eye.2009.235","volume":"23","author":"B Damato","year":"2009","unstructured":"Damato B, Coupland SE: A reappraisal of the significance of largest basal diameter of posterior uveal melanoma. Eye (Lond). 2009, 23: 2152-2160. 10.1038\/eye.2009.235.","journal-title":"Eye (Lond)"},{"key":"417_CR31","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/S0161-6420(95)30947-5","volume":"102","author":"V Rummelt","year":"1995","unstructured":"Rummelt V, Folberg R, Woolson RF, Hwang T, Pe\u2019er J: Relation between the microcirculation architecture and the aggressive behavior of ciliary body melanomas. Ophthalmology. 1995, 102: 844-851. 10.1016\/S0161-6420(95)30947-5.","journal-title":"Ophthalmology"},{"key":"417_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1054\/mehy.2000.1119","volume":"56","author":"DT Janerich","year":"2001","unstructured":"Janerich DT: The fetal antigen hypothesis: cancers and beyond. Med Hypotheses. 2001, 56: 101-103. 10.1054\/mehy.2000.1119.","journal-title":"Med Hypotheses"},{"key":"417_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1258\/096914105775220642","volume":"12","author":"NJ Wald","year":"2005","unstructured":"Wald NJ, Morris JK, Rish S: The efficacy of combining several risk factors as a screening test. J Med Screen. 2005, 12: 197-201. 10.1258\/096914105775220642.","journal-title":"J Med Screen"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-14-42.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2415-14-42\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-14-42","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-14-42.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T03:15:17Z","timestamp":1548213317000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/1471-2415-14-42"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["417"],"URL":"https:\/\/doi.org\/10.1186\/1471-2415-14-42","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,1]]},"article-number":"42"}}